Answers are grounded in this paper and cite their sources.
• HOXB2/3/7 and HOXD3/8/9/10/11/13 expression was higher in GBM samples compared to normal samples. • Increased expression of HOXB2/5/8/9/13 was associated with negative effects on survival of patients. • Overexpression of HOXB2/5/9 was linked to inferior progression free survival. • Heightened levels of HOXD4/9, HOXD9/11, and HOXD9/10/11 in GBM were correlated with unfavorable outcomes. • HOXB2 and HOXD3 expression potentially causes resistance to Methotrexate and Z-LLNle-CHO. Glioblastoma is an aggressive cancer that affects the brain. The Homeobox B and D ( HOXB/D ) family has been linked to tumor progression, but their exact mechanism remains unclear. This study aimed to identify critical HOXB/D family members associated with glioblastoma and analyze their expression in glioblastoma using the GEPIA2 database. The study also assessed genetic alterations, their related transcription factors, miRNAs, gene-gene interactions, and correlations between their expression and immune infiltration using databases like cBioPortal, miRNet, GeneMANIA, and GSCA. We showed that HOXB2/3/7 and HOXD3/8/9/10/11/13 expression was higher in glioblastoma samples compared to normal samples. Increased expression of HOXB2/5/8/9/13 was associated with negative effects on overall survival (OS), disease-specific survival (DSS), and progression-free survival (PFS), while overexpression of HOXB2/5/9 was linked to inferior PFS. Heightened levels of HOXD4/9, HOXD9/11 , and HOXD9/10/11 expression in glioblastoma patients were correlated with unfavorable outcomes in terms of OS, DSS, and PFS. HOXB/D genes were related to 20 different genes, mainly enriched in the Activation of HOX Genes During Differentiation R-HSA-5619507 pathway. Immune cells were linked to specific genes in glioblastoma, with HOXB2 and HOXD3 expression potentially causing resistance to Methotrexate and Z-LLNle-CHO, HOXB7 indicating sensitivity to Lapatinib but resistance to 18 other small molecules, HOXD8 leading to resistance against 5 small molecules, and upregulated HOXD9, HOXD10 , and HOXD13 suggesting sensitivity to 2, 4, and 9 small molecules, respectively. Taken together, we showed contribution of HOXB and HOXD genes in the carcinogenic processes and proposed them as possible targets for treatment options.
No takes yet. Share an insight, caveat, or question.
Ahmadi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: